Clinical Efficacy on Modified Prescription of Danggui Shaoyao San Combined with Yiyi Fuzi Baijiang San in Treating Moderate or Severe Acne with Damp-heat Blood Syndrome

LU Xiao-yan; GAN Cai-bin; ZHANG Xiao-ning

doi:10.13422/j.cnki.syfjx.2016230176

您当前的位置：

首页 >

文章列表页 >

Clinical Efficacy on Modified Prescription of Danggui Shaoyao San Combined with Yiyi Fuzi Baijiang San in Treating Moderate or Severe Acne with Damp-heat Blood Syndrome

更新时间：2024-01-04

- Clinical Efficacy on Modified Prescription of Danggui Shaoyao San Combined with Yiyi Fuzi Baijiang San in Treating Moderate or Severe Acne with Damp-heat Blood Syndrome
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 22, Issue 23, Pages: 176-180(2016)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2016230176
  CLC： R275.9
- Published：2016
- 稿件说明：
移动端阅览
LU Xiao-yan, GAN Cai-bin, ZHANG Xiao-ning. Clinical Efficacy on Modified Prescription of Danggui Shaoyao San Combined with Yiyi Fuzi Baijiang San in Treating Moderate or Severe Acne with Damp-heat Blood Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(23): 176-180.
DOI：

LU Xiao-yan, GAN Cai-bin, ZHANG Xiao-ning. Clinical Efficacy on Modified Prescription of Danggui Shaoyao San Combined with Yiyi Fuzi Baijiang San in Treating Moderate or Severe Acne with Damp-heat Blood Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(23): 176-180. DOI： 10.13422/j.cnki.syfjx.2016230176.

摘要

目的：观察当归芍药散合薏苡附子败酱散加减治疗中、重度痤疮湿热瘀结证的临床疗效作用及对血清白细胞介素-1α（IL-1α），白细胞介素8（IL-8），肿瘤坏死因子-α（TNF-α），胰岛素样生长因子-1（IGF-1）水平的影响。方法：将符合要求的152例患者按就诊先后采用随机数字表法分为对照组75例和联合组77例。20例受试者作为健康对照组。对照组Ⅱ级患者使用他扎罗汀倍他米松乳膏，适量外涂，2次/d；Ⅲ级患者在使用外涂的同时，口服盐酸多西环素片，100 mg/次，2次/d；Ⅳ级患者，在此基础上给予阿维A胶囊，20 mg/次，2次/d，服用4周。联合组在对照组治疗的基础上加用当归芍药散和薏苡附子败酱散加减治疗。两组疗程均为8周。进行治疗前后皮损严重程度评分（GAGS）和中医证候评分，进行治疗前后痤疮患者特异性生活质量量表（Acne-QOL）评分；检测治疗前后IL-1α，IL-8，TNF-α，IGF-1水平。结果：联合组总有效率为90.91%，高于对照组的78.67%（P<0.05）；治疗后联合组GAGS评分和中医证候评分均低于对照组（P<0.01）；治疗后联合组Acne-QOL量表4个维度（自我感知、情感功能、痤疮症状、社会功能）评分和总分均高于对照组（P<0.01）；与健康对照组比较，两组患者血清IL-1α，IL-8，TNF-α和IGF-1水平均明显升高（P<0.01）；治疗后两组IL-1α，IL-8，TNF-α和IGF-1水平均较治疗前下降（P<0.01），治疗后联合组IL-1α，IL-8，TNF-α和IGF-1水平低于对照组（P<0.01），但仍高于健康对照组（P<0.01）。结论：在常规西医分级治疗的基础上加服当归芍药散合薏苡附子败酱散加减治疗中、重度痤疮患者，能减轻患者皮损程度，改善中医症状，提高疾病的临床疗效和生活质量，其作用机制可能与下调血清IL-1α，IL-8，TNF-α和IGF-1水平有关。

Abstract

Objective: To observe the clinical efficacy of modified prescription of Danggui Shaoyao San combined with Yiyi Fuzi Baijiang San in treating moderate or severe acne with damp-heat blood stasis syndrome

and its effect on levels of interleukin-1α (IL-1α)

interleukin-8 (IL-8)

itumor necrosis factor-α (TNF-α) and insulin-like growth factor-1 (IGF-1). Method: One hundred and fifty-two patients were randomly divided into control group (75 cases) and combination group (77 cases) by random number table

with the other 20 subjects in healthy control group. The grade Ⅱ patients in control group took Tazarotene and Betamethasone Dipropionate Cream

2 times/day. The grade Ⅲ patients were additionally administered with Doxycycline Hyclate tablets

100 mg/time

2 times/day. The grade Ⅳ patients were additionally given Acitretin capsules

20 mg/time

2 times/day

for 4 weeks. In addition to the therapy of control group

the patients in combination group was additionally administered with modified prescription of Danggui Shaoyao San combined with Yiyi Fuzi Baijiang San. The courses of treatment were 8 months. Before and after the treatment

Global Acne Grading System (GAGS)

traditional Chinese medicine(TCM) syndromes and Acne-quality of life (QOL) were scored. And levels of IL-1α

IL-8

TNF-α and IGF-1 were detected. Result: The total clinical effective rate in combination group was 90.91%

which was higher than 78.67% in control group (P<0.05). Scores of GAGS and TCM symptoms in combination group were lower than those in control group (P<0.01). Scores of Acne-QOL scale (self-perception

emotional function

symptoms of acne and social function) and the total scores in combination group were higher than those in control group (P<0.01). Combined with health control group

levels of IL-1α

IL-8

TNF-α and IGF-1 increased in the two groups (P<0.01). After the treatment

levels of IL-1α

IL-8

TNF-α and IGF-1 decreased in the two groups (P<0.01). And levels of IL-1α

IL-8

TNF-α and IGF-1 in combination group were lower than those in control group (P<0.01). But still higher than the healthy control group. Conclusion: In addition to the therapy of western medicine

modified prescription of Danggui Shaoyao San combined with Yiyi Fuzi Baijiang San can relieve injuries on the face

ameliorate TCM symptoms

improve clinical efficacy and quality of life

and the action mechanism may be correlated with down-regulation of levels of IL-1α

IL-8

TNF-α and IGF-1.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Study of Internal and External Treatment of Gegen Qinlian Wutan Decoction in Active Ulcerative Colitis

Suhuang Zhike Capsule in the Treatment of Acute Exacerbation of Chronic Bronchitis Clinical Observation

Mechanism and Effect of Xiaoer Feike Granule on Post-infection Cough

Effect of Xuanfei Pingchuan Capsules on Rat COPD Model

Clinical Observation of Tiaojing Zhuyu Decoction on Polycystic Ovarian Syndrome with Ovulation Inhibition and Syndrome of Kidney Deficiency and Blood Stasis

Related Author

WANG Yan-mei

KANG Mei-qing

CUI Yan-bing

XING Zhi-xia

WANG Rui-fang

XU Jian-xin

WANG Hong-yu

GUO Xin

Related Institution

The First Affiliated Hospital of Guizhou University of TCM

Guizhou University of Traditional Chinese Medicine（TCM）

Graduate School of Hebei University of Chinese Medicine

School of Integrated Traditional Chinese and Western Medicine，Hebei University of Chinese Medicine

Traditional Chinese Hall，Hebei University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰